Address
100 Abbott Park Road
Abbott Park, IL 60064-6400
United States of America (the)
Phone
224 667 6100
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
114000
First IPO Date
March 17, 1980
| Name | Title | Pay | Year Born |
| Robert Ford | Chairman, Pres & Chief Executive Officer | 4.43M | 1974 |
| Daniel Gesua Sive Salvadori | Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products | 1.52M | 1979 |
| Christopher J. Scoggins | Executive Vice President of Diabetes Care | 2.06M | 1970 |
| Philip Boudreau | Chief Financial Officer & Executive Vice President of Finance | 2.1M | 1973 |
| Lisa D. Earnhardt | Executive Vice President & Group President of Medical Devices | 2.39M | 1970 |
| Elizabeth Cushman | Executive Vice President, General Counsel & Secretary | 2.55M | 1970 |
| Scott Michael Leinenweber | Senior Vice President of Licensing, Acquisitions & Ventures | 0 | 1972 |
| Mary K. Moreland | Executive Vice President of Human Resources | 0 | 1966 |
| Michael Comilla | Vice President of Investor Relations. | 0 | N/A |
| Sabina Ewing | Senior Vice President of Business & Technology Services and Chief Information Officer | 0 | 1974 |
| Erica L. Battaglia | Vice President and Chief Ethics & Compliance Officer | 0 | N/A |
| Melissa Brotz | Senior Vice President of Global Marketing & External Affairs | 0 | N/A |
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.